المؤلفون: Bous, J, Fouillen, A, Orcel, H, Trapani, S, Cong, XJ, Fontanel, S, Saint-Paul, J, Lai-Kee-Him, J, Urbach, S, Sibille, N, Sounier, R, Granier, S, Mouillac, B, Bron, P

المصدر: Science advances. 8(35)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:151348776

المؤلفون: Cohen, EEW, Licitra, LF, Burtness, B, Fayette, J, Gauler, T, Clement, PM, Grau, JJ, del Campo, JM, Mailliez, A, Haddad, RI, Vermorken, JB, Tahara, M, Guigay, J, Geoffrois, L, Merlano, MC, Dupuis, N, Krämer, N, Cong, XJ, Gibson, N, Solca, F, Ehrnrooth, E, Machiels, J-PH

المصدر: Annals of Oncology. 28(10)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Dental/Oral and Craniofacial Disease, Rare Diseases, Cancer, Clinical Research, 4.2 Evaluation of markers and technologies, Detection, screening and diagnosis, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Good Health and Well Being, Administration, Intravenous, Administration, Oral, Afatinib, Antimetabolites, Antineoplastic, Biomarkers, Tumor, Biopsy, Carcinoma, Squamous Cell, Disease-Free Survival, Head and Neck Neoplasms, Humans, Methotrexate, Neoplasm Metastasis, Neoplasm Recurrence, Local, Predictive Value of Tests, Quinazolines, Squamous Cell Carcinoma of Head and Neck, afatinib, methotrexate, HNSCC, biomarker, phase III, EGFR, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/1p0153q0

المؤلفون: Clement, PM, Gauler, T, Machiels, JP, Haddad, RI, Fayette, J, Licitra, LF, Tahara, M, Cohen, EEW, Cupissol, D, Grau, JJ, Guigay, J, Caponigro, F, de Castro, G, de Souza Viana, L, Keilholz, U, del Campo, JM, Cong, XJ, Ehrnrooth, E, Vermorken, JB

المصدر: Annals of Oncology. 27(8)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Dental/Oral and Craniofacial Disease, Cancer, Clinical Trials and Supportive Activities, Rare Diseases, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Good Health and Well Being, Afatinib, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Disease-Free Survival, Female, Head and Neck Neoplasms, Humans, Male, Methotrexate, Neoplasm Metastasis, Neoplasm Recurrence, Local, Platinum, Quinazolines, Squamous Cell Carcinoma of Head and Neck, Treatment Outcome, LUX-H&N 1 investigators, HNSCC, afatinib, methotrexate, older, phase III, second-line, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/5569t3kk

المؤلفون: Hirsh V, Cadranel J, Cong XJ, Fairclough D, Finnern HW, Lorence RM, Miller VA, Palmer M, Yang JC, Hirsh, Vera, Cadranel, Jacques, Cong, Xiuyu Julie, Fairclough, Diane, Finnern, Henrik W, Lorence, Robert M, Miller, Vince A, Palmer, Michael, Yang, James Chih-Hsin

المصدر: Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, p229-237, 9p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Xu B; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Ma F; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang T; Department of Breast Cancer, The Fifth Medical Center of PLA General Hospital, Beijing, China., Wang S; Department of Medical Oncology, Sun Yet-Sen University Cancer Center, Guangzhou, China., Tong Z; Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Li W; Department of Medical Oncology, The First Hospital of Jilin University, Changchun, China., Wu X; Department of Breast Oncology, Hubei Cancer Hospital, Wuhan, China., Wang X; Department of Breast Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Sun T; Department of Medical Oncology, Liaoning Cancer Hospital &Institute, Shenyang, China., Pan Y; Department of Medical Oncology, Anhui Provincial Hospital, Hefei, China., Yao H; Department of Medical Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Wang X; Department of Medical Oncology, Sir Run Run Shaw Hospital, Hangzhou, China., Luo T; Department of Head, Neck and Mammary Gland Oncology, West China Hospital, Sichuan University, Chengdu, China., Yang J; Department of Medical Oncology, First Affiliated Hospital of Xian Jiaotong University, Xi'an, China., Zeng X; Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China., Zhao W; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China., Cong XJ; Everest Medicines, Shanghai, China., Chen J; Everest Medicines, Shanghai, China.

المصدر: International journal of cancer [Int J Cancer] 2023 May 15; Vol. 152 (10), pp. 2134-2144. Date of Electronic Publication: 2023 Jan 30.

نوع المنشور: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/pathology , Immunoconjugates*, Humans ; Female ; Middle Aged ; East Asian People ; Neoplasm Recurrence, Local/drug therapy ; Camptothecin

المؤلفون: Zhang F; Pfizer Inc., Groton, CT, USA., Chen MH; Department of Statistics, University of Connecticut, Storrs, CT, USA., Cong XJ; Everest Medicines, Shanghai, China., Chen Q; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.

المصدر: Statistical modelling [Stat Modelling] 2021 Feb 01; Vol. 21 (1-2), pp. 30-55. Date of Electronic Publication: 2020 Jul 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Arnold Country of Publication: England NLM ID: 101314442 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1471-082X (Print) Linking ISSN: 1471082X NLM ISO Abbreviation: Stat Modelling Subsets: PubMed not MEDLINE

المؤلفون: Chen Q; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. cindy.chen@vumc.org., Zhang F; Pfizer Inc., Groton, CT, 06340, USA., Chen MH; Department of Statistics, University of Connecticut, 215 Glenbrook Road, U-4120, Storrs, CT, 06269, USA., Cong XJ; Everest Medicines, Shanghai, China.

المصدر: Lifetime data analysis [Lifetime Data Anal] 2020 Oct; Vol. 26 (4), pp. 685-707. Date of Electronic Publication: 2020 Mar 03.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9516348 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1572-9249 (Electronic) Linking ISSN: 13807870 NLM ISO Abbreviation: Lifetime Data Anal Subsets: MEDLINE

مواضيع طبية MeSH: Likelihood Functions* , Survival Analysis* , Treatment Switching*, Randomized Controlled Trials as Topic/*methods, Algorithms ; Computer Simulation ; Head and Neck Neoplasms ; Humans

المؤلفون: Han RF; Department of Pediatrics, Yantaishan Hospital, Yantai, Shandong, China. ythwcxj@163.com., Li HY, Wang JW, Cong XJ

المصدر: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2016 May; Vol. 20 (10), pp. 2151-5.

نوع المنشور: Clinical Study; Journal Article

بيانات الدورية: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Adjuvants, Immunologic/*pharmacology , Asthma/*drug therapy , Bronchitis/*drug therapy , Cell Extracts/*pharmacology, Adjuvants, Immunologic/therapeutic use ; Asthma/complications ; Asthma/immunology ; Bronchitis/immunology ; Cell Extracts/therapeutic use ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Random Allocation ; Treatment Outcome

المؤلفون: Machiels JP; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels. Electronic address: jean-pascal.machiels@uclouvain.be., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School and Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Fayette J; Léon Bérard Center and Hospices Civils de Lyon, University of Lyon, Lyon, France., Licitra LF; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Tahara M; National Cancer Center Hospital East, Kashiwa, Japan., Vermorken JB; Antwerp University Hospital, Edegem, Belgium., Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium., Gauler T; West German Cancer Center, University Hospital Essen, Essen, Germany., Cupissol D; Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Grau JJ; Hospital Clínic de Barcelona, University of Barcelona, Spain., Guigay J; Gustave Roussy, Villejuif and Centre Antoine Lacassagne, Nice, France., Caponigro F; Division of Head and Neck Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale'-IRCCS, Naples, Italy., de Castro G Jr; Instituto do Câncer do Estado de São Paulo, Brazil., de Souza Viana L; Hospital de Câncer de Barretos, São Paulo, Brazil., Keilholz U; Charité Comprehensive Cancer Center, Berlin, Germany., Del Campo JM; Medical Oncology Department, Hospital Universitario Vall D'Hebron, Barcelona, Spain., Cong XJ; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA., Ehrnrooth E; Boehringer Ingelheim, Danmark A/S, Denmark., Cohen EE; University of California San Diego Moores Cancer Center, La Jolla, CA, USA.

مؤلفون مشاركون: LUX-H&N 1 investigators

المصدر: The Lancet. Oncology [Lancet Oncol] 2015 May; Vol. 16 (5), pp. 583-94. Date of Electronic Publication: 2015 Apr 16.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Carcinoma, Squamous Cell/*drug therapy , Head and Neck Neoplasms/*drug therapy , Methotrexate/*administration & dosage , Neoplasm Recurrence, Local/*drug therapy , Quinazolines/*administration & dosage, Adult ; Afatinib ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/pathology ; Platinum/administration & dosage ; Squamous Cell Carcinoma of Head and Neck ; Treatment Outcome